AdvtAdvtJoin the community of 2M+ industry professionals. Subscribe to Newsletter to get latest insights & analysis in your inbox. Download the ETPharma App and get the Realtime updates and Save your favourite articles. His tenure included a series of high-profile disputes over product reviews for vaccines, including Moderna's COVID shot, gene therapies and other rare disease drugs.He was appointed as the director of the FDA's Center for Biologics Evaluation and Research in May last year. (Reporting by Christy Santhosh and Kamal Choudhury in Bengaluru; Michael Erman in New York; Editing by Sriraj Kalluvila, Shinjini Ganguli, and Caroline Humer)>
